Detalhe da pesquisa
1.
A real-world retrospective-prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.
Cancer Med
; 13(7): e7071, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38558233
2.
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma.
Cancers (Basel)
; 13(23)2021 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34885198